(주)셀렉스라이프사이언스

About Us

ILIAS is the Leader of Next-Generation Exosome Therapeutics.

Taejin Ham, RPh, MBA EVP, Chief Operating Officer

Taejin Ham brings over 20 years of global business experience in successfully building and managing various organizations in pharmaceutical and biotechnology industry. He was Country General Manager at Celgene Corporation in Korea and Taiwan affiliates, leading strong business growth in both countries. He also served as head of strategy and marketing functions at Celgene's Asia-Pacific regional headquarter in Singapore. Prior to Celgene, Taejin worked for Eli Lilly and Company in multiple leadership roles including Cluster General Manager in Singapore, Malaysia, and Brunei, Head of Market Access and Corporate Affairs in South Korea, and International Brand Leader at global headquarter in USA.

A pharmacist by training and MS in pharmaceutical science, Taejin started his career as research scientist at CJ CheilJedang (formerly a Samsung company), and then pursued MBA from the Wharton School of the University of Pennsylvania.

Back

개인정보취급방침

닫기

이메일주소무단수집거부

닫기

사이트맵

사이트맵

몬트리올의정서
국내이행법령
사업안내
특정물질 수출입
알림·자료실
민원서비스
닫기